Plugging the $413 Billion Dollar Drain: Precision Medicine and ADA’s Fight to Prevent Diabetes

Rome talks with Dr. Osagie Ebekozien, Chief Quality Officer of the American Diabetes Association (ADA), for a powerful conversation around the staggering $413 billion annual cost of diabetes in the U.S. Dr. Ebekozien illuminates 85 years of the ADA’s work and how precision medicine offers a vital path to preventing diabetes and mitigating its profound impact on health and healthcare budgets. He also shares his personal inspiration for fighting diabetes and explains the crucial link between diabetes and obesity, highlighting how conditions like prediabetes affect millions and escalate costs.Discover the transformative role of modern treatments like GLP-1s, a true success story of precision medicine, and programs like the National Diabetes Prevention Program in delaying or preventing the disease. Dr. Ebekozien emphasizes that by taking an active role in understanding your health, engaging with care providers, and advocating for widespread solutions, we can collectively reduce this epidemic and ultimately cure diabetes. Key Takeaways:The Alarming Cost: Diabetes drains $413 billion annually from the U.S. economy, often impacting family budgets through complications.Precision Prevention: Genetic testing helps identify diabetes subtypes (e.g., monogenic, T1D stages) for earlier, more effective interventions.GLP-1's Impact: Medications like GLP-1s showcase the power of precision medicine in managing diabetes and obesity, improving outcomes significantly.Empowering Action: Learn practical steps for understanding personal risk, preventing prediabetes from progressing, and advocating for better care.